Literature DB >> 22160228

[Malignant lymphoma of the skin: update on diagnostics and therapy of primary cutaneous B-cell lymphoma].

C Hallermann1, C Niermann, M Fluck, A-R Fischedick, H-J Schulze.   

Abstract

The diagnosis of primary cutaneous B-cell lymphoma is made based principally on the results of histological investigations and staging. For an exact staging abdominal sonography and chest X-ray examinations and for appropriate clinical symptoms special investigations as well as radiological imaging procedures including PET are indicated in addition to conventional laboratory investigations. For therapy rituximab is normally administered as monotherapy in order to avoid over therapy of indolent lymphoma. Further options are radiotherapy and new approaches with electrochemotherapy as well as pegylated doxorubicin.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22160228     DOI： 10.1007/s00105-011-2275-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  36 in total

1.  Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.

Authors:  Juliette J Hoefnagel; Remco Dijkman; Katia Basso; Patty M Jansen; Christian Hallermann; Rein Willemze; Cornelis P Tensen; Maarten H Vermeer
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

2.  Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association.

Authors:  Gaia Goteri; Renzo Ranaldi; Oriana Simonetti; Roberta Capretti; Stefano Menzo; Daniela Stramazzotti; Doriana Morichetti; Anna Maria Offidani; Serena Rupoli; Pietro Leoni
Journal:  Leuk Lymphoma       Date:  2007-11

3.  Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma.

Authors:  L Cerroni; N Zöchling; B Pütz; H Kerl
Journal:  J Cutan Pathol       Date:  1997-09       Impact factor: 1.587

4.  Cutaneous features of intravascular lymphoma.

Authors:  S Wahie; S Dayala; A Husain; G Summerfield; V Hervey; J A A Langtry
Journal:  Clin Exp Dermatol       Date:  2010-09-16       Impact factor: 3.470

5.  Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.

Authors:  Christian Hallermann; Christoph Niermann; Rudolf-Josef Fischer; Hans-Joachim Schulze
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

Review 6.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

7.  Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.

Authors:  Florent Grange; Tony Petrella; Marie Beylot-Barry; Pascal Joly; Michel D'Incan; Michele Delaunay; Laurent Machet; Marie-Francoise Avril; Sophie Dalac; Philippe Bernard; Agnes Carlotti; Eric Esteve; Beatrice Vergier; Pierre Dechelotte; Elisabeth Cassagnau; Philippe Courville; Philippe Saiag; Liliane Laroche; Martine Bagot; Janine Wechsler
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

8.  Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas.

Authors:  Christian Hallermann; Kjell M Kaune; Reiner Siebert; Maarten H Vermeer; Cees P Tensen; Rein Willemze; Bastian Gunawan; Hans Peter Bertsch; Christine Neumann
Journal:  J Invest Dermatol       Date:  2004-06       Impact factor: 8.551

9.  Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.

Authors:  Willeke A M Blokx; Monique P M Andriessen; Henk W van Hamersvelt; Johan H J M van Krieken
Journal:  Am J Dermatopathol       Date:  2002-10       Impact factor: 1.533

10.  Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients.

Authors:  J Valencak; F Weihsengruber; K Rappersberger; F Trautinger; A Chott; B Streubel; L Muellauer; M Der-Petrossian; C Jonak; M Binder; M Raderer
Journal:  Ann Oncol       Date:  2008-10-03       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.